IndraLab

Statements

CRM197 activates SCN1A. 1 / 1

| 1

reach

"CRM197 reverses paclitaxel resistance by inhibiting the NAC-1 and Gadd45 pathway in paclitaxel resistant ovarian cancer cells."

31490008

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

CRM197 activates SCN1A. 1 / 1

INDRA sources:

Databases

Reading